122 related articles for article (PubMed ID: 31221413)
1. Modelling the effect of spread in radiosensitivity parameters and repopulation rate on the probability of tumour control.
Stavreva N; Stavrev P; Balabanova A; Nahum A; Ruggieri R; Pressyanov D
Phys Med; 2019 Jul; 63():79-86. PubMed ID: 31221413
[TBL] [Abstract][Full Text] [Related]
2. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
3. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
4. On differences in radiosensitivity estimation: TCP experiments versus survival curves. A theoretical study.
Stavrev P; Stavreva N; Ruggieri R; Nahum A
Phys Med Biol; 2015 Aug; 60(15):N293-9. PubMed ID: 26215150
[TBL] [Abstract][Full Text] [Related]
5. Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression.
Fenwick JD
Phys Med Biol; 1998 Aug; 43(8):2159-78. PubMed ID: 9725596
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo dose calculations and radiobiological modelling: analysis of the effect of the statistical noise of the dose distribution on the probability of tumour control.
Buffa FM; Nahum AE
Phys Med Biol; 2000 Oct; 45(10):3009-23. PubMed ID: 11049185
[TBL] [Abstract][Full Text] [Related]
7. Are more complicated tumour control probability models better?
Gong J; Dos Santos MM; Finlay C; Hillen T
Math Med Biol; 2013 Mar; 30(1):1-19. PubMed ID: 22006625
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of heterogeneous target dose and heterogeneous radiosensitivity on tumor control probability for different fractionation regimens.
Kuperman VY; Lubich LM; Spradlin GS
Phys Med; 2022 Mar; 95():140-147. PubMed ID: 35176720
[TBL] [Abstract][Full Text] [Related]
9. A method to visualize the uncertainty of the prediction of radiobiological models.
Zhang L; Hub M; Thieke C; Floca RO; Karger CP
Phys Med; 2013 Sep; 29(5):556-61. PubMed ID: 23260766
[TBL] [Abstract][Full Text] [Related]
10. The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.
Ruggieri R; Nahum AE
Med Phys; 2006 Nov; 33(11):4044-55. PubMed ID: 17153384
[TBL] [Abstract][Full Text] [Related]
11. Effect of heterogeneous target dose and radiosensitivity on BED and TCP for different treatment regimens.
Kuperman VY; Lubich LM
Phys Med Biol; 2021 Jul; 66(15):. PubMed ID: 33910174
[No Abstract] [Full Text] [Related]
12. Viability of the EUD and TCP concepts as reliable dose indicators.
Ebert MA
Phys Med Biol; 2000 Feb; 45(2):441-57. PubMed ID: 10701514
[TBL] [Abstract][Full Text] [Related]
13. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols.
Levin-Plotnik D; Hamilton RJ
Phys Med Biol; 2004 Feb; 49(3):407-24. PubMed ID: 15012010
[TBL] [Abstract][Full Text] [Related]
14. Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data.
Sanchez-Nieto B; Nahum AE; Dearnaley DP
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):487-99. PubMed ID: 11173145
[TBL] [Abstract][Full Text] [Related]
15. Influence of inhomogeneous radiosensitivity distributions and intrafractional organ movement on the tumour control probability of focused IMRT in prostate cancer.
Thomann B; Sachpazidis I; Koubar K; Zamboglou C; Mavroidis P; Wiehle R; Grosu AL; Baltas D
Radiother Oncol; 2018 Apr; 127(1):62-67. PubMed ID: 29548559
[TBL] [Abstract][Full Text] [Related]
16. A stochastic model for tumour control probability that accounts for repair from sublethal damage.
Ponce Bobadilla AV; Maini PK; Byrne H
Math Med Biol; 2018 Jun; 35(2):181-202. PubMed ID: 28339783
[TBL] [Abstract][Full Text] [Related]
17. Should single or distributed parameters be used to explain the steepness of tumour control probability curves?
Daşu A; Toma-Daşu I; Fowler JF
Phys Med Biol; 2003 Feb; 48(3):387-97. PubMed ID: 12608614
[TBL] [Abstract][Full Text] [Related]
18. Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy.
Her EJ; Reynolds HM; Mears C; Williams S; Moorehouse C; Millar JL; Ebert MA; Haworth A
Phys Med Biol; 2018 Jun; 63(13):135011. PubMed ID: 29799812
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the effect of natural tumor cell death on radiotherapy outcomes.
Stavrev P; Stavreva N; Penev D; Nahum A; Ruggieri R; Pressyanov D
Phys Med Biol; 2018 Oct; 63(20):205001. PubMed ID: 30204124
[TBL] [Abstract][Full Text] [Related]
20. Cell-cycle times and the tumour control probability.
Maler A; Lutscher F
Math Med Biol; 2010 Dec; 27(4):313-42. PubMed ID: 19966342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
